Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study. - Yu, Jie-Hai; Xiao, Bin-Yi; Li, Dan-Dan; Jiang, Wu; Ding, Ya; Wu, Xiao-Jun; Zhang, Rong-Xin; Lin, Jun-Zhong; Wang, Wei; Han, Kai; Kong, Ling-Heng; Zhang, Xin-Ke; et al. (Lancet Oncology, 2024)